KPRX logo

Kiora Pharmaceuticals (KPRX) Cash From Investing

Annual CFI

$0.00
-$6400.00-100.00%

December 1, 2023

Summary

Performance

1-Year Change

-100%

3-Year Change

+100%

5-Year Change

+100%

15-Year Change

+100%

KPRX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.59%
KPRX annual cash flow from investing activities is higher than 67.59% of companies in Healthcare sector

High & Low

All-time High

$174.70 K
KPRX annual cash flow from investing activities is currently -100.00% below its historical high of $174.70 thousand

3-Year Low

-$157.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
KPRX previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
KPRX next annual earnings announcement has not yet been scheduled

OtherKPRXcash flowmetrics:

Annual CFF

$5.97 M
KPRX annual cash flow from financing activities is $5.97 million

Annual CFO

-$9.56 M
KPRX annual cash flow from operations is -$9.56 million

Annual FCF

-$9.56 M
KPRX annual free cash flow is -$9.56 million

Annual CAPEX

-
KPRX annual capital expenditures value is unknown

Quarterly CFI

-$1.92 M
+$19.30 M+90.95%

September 1, 2024

Summary

Performance

3-Month Change

+90.95%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

KPRX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.61%
KPRX quarterly cash flow from investing activities is higher than 31.61% of companies in Healthcare sector

High & Low

All-time High

$175.70 K
KPRX quarterly cash flow from investing activities is currently -1193.00% below its historical high of $175.70 thousand

3-Year Low

-$21.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
KPRX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
KPRX next earnings announcement has not yet been scheduled

OtherKPRXcash flowmetrics:

Quarterly CFF

$0.00
KPRX quarterly cash flow from financing activities is $0.00

Quarterly CFO

$920.10 K
KPRX quarterly cash flow from operations is $920.10 thousand

Quarterly FCF

$920.10 K
KPRX quarterly free cash flow is $920.10 thousand

Quarterly CAPEX

-
KPRX quarterly capital expenditures value is unknown

TTM CFI

-$23.15 M
-$1.92 M-9.05%

September 1, 2024

Summary

Performance

3-Month Change

-9.05%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

KPRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.79%
KPRX TTM cash flow from investing activities is higher than 27.79% of companies in Healthcare sector

High & Low

All-time High

$175.70 K
KPRX TTM cash flow from investing activities is currently <-9900.00% below its historical high of $175.70 thousand

3-Year Low

-$23.15 M
KPRX TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
KPRX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
KPRX next earnings announcement has not yet been scheduled

OtherKPRXcash flowmetrics:

TTM CFF

$15.01 M
KPRX TTM cash flow from financing activities is $15.01 million

TTM CFO

$8.23 M
KPRX TTM cash flow from operations is $8.23 million

TTM FCF

$8.18 M
KPRX TTM free cash flow is $8.18 million

TTM CAPEX

-
KPRX TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KPRX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-100.0%
3 y3 years+100.0%-100.0%-100.0%
5 y5 years+100.0%-100.0%-100.0%

KPRX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%+100.0%<-9999.0%+91.0%<-9999.0%at low
5 y5-year-100.0%+100.0%<-9999.0%+91.0%<-9999.0%at low
alltimeall time-100.0%+100.0%-1193.0%+91.0%<-9999.0%at low

Kiora Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.92 M(-91.0%)
-$23.15 M(+9.0%)
Jun 2024
-
-$21.22 M(<-9900.0%)
-$21.22 M(<-9900.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2022
$6400.00(-104.1%)
$0.00(0.0%)
$6400.00(-107.4%)
Sep 2022
-
$0.00(0.0%)
-$86.80 K(0.0%)
Jun 2022
-
$0.00(-100.0%)
-$86.80 K(-6.2%)
Mar 2022
-
$6400.00(-106.9%)
-$92.50 K(-41.1%)
Dec 2021
-$157.00 K(-35.8%)
-$93.20 K(<-9900.0%)
-$157.00 K(-49.1%)
Sep 2021
-
$0.00(-100.0%)
-$308.20 K(0.0%)
Jun 2021
-
-$5700.00(-90.2%)
-$308.20 K(+1.9%)
Mar 2021
-
-$58.10 K(-76.2%)
-$302.50 K(+23.8%)
Dec 2020
-$244.40 K(<-9900.0%)
-$244.40 K(<-9900.0%)
-$244.40 K(<-9900.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2019
$0.00(-100.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2018
-$270.00 K(+629.7%)
$0.00(-100.0%)
-$270.00 K(-12.1%)
Sep 2018
-
-$270.00 K(+629.7%)
-$307.00 K(+729.7%)
Dec 2017
-$37.00 K(-121.2%)
-$37.00 K(<-9900.0%)
-$37.00 K(-248.0%)
Sep 2017
-
$0.00(-100.0%)
$25.00 K(-85.7%)
Dec 2016
$174.70 K(-973.5%)
$25.00 K(-327.3%)
$174.70 K(+16.7%)
Sep 2016
-
-$11.00 K(-26.7%)
$149.70 K(-6.8%)
Jun 2016
-
-$15.00 K(-108.5%)
$160.70 K(-8.5%)
Mar 2016
-
$175.70 K(>+9900.0%)
$175.70 K(-978.5%)
Dec 2015
-$20.00 K(<-9900.0%)
$0.00(0.0%)
-$20.00 K(0.0%)
Sep 2015
-
$0.00(0.0%)
-$20.00 K(0.0%)
Jun 2015
-
$0.00(-100.0%)
-$20.00 K(0.0%)
Mar 2015
-
-$20.00 K(<-9900.0%)
-$20.00 K(<-9900.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00
$0.00
Dec 2012
$0.00
-
-

FAQ

  • What is Kiora Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals annual CFI year-on-year change?
  • What is Kiora Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals quarterly CFI year-on-year change?
  • What is Kiora Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals TTM CFI year-on-year change?

What is Kiora Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of KPRX is $0.00

What is the all time high annual CFI for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high annual cash flow from investing activities is $174.70 K

What is Kiora Pharmaceuticals annual CFI year-on-year change?

Over the past year, KPRX annual cash flow from investing activities has changed by -$6400.00 (-100.00%)

What is Kiora Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of KPRX is -$1.92 M

What is the all time high quarterly CFI for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high quarterly cash flow from investing activities is $175.70 K

What is Kiora Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, KPRX quarterly cash flow from investing activities has changed by -$1.92 M (-100.00%)

What is Kiora Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of KPRX is -$23.15 M

What is the all time high TTM CFI for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high TTM cash flow from investing activities is $175.70 K

What is Kiora Pharmaceuticals TTM CFI year-on-year change?

Over the past year, KPRX TTM cash flow from investing activities has changed by -$23.15 M (-100.00%)